MICROBIOLOGY LABORATORY SERVICES

Laboratory Services Ready for Clinical Trials

Introduction and Scope

In clinical research, microbiology plays a critical role in patient safety, biological risk management, and data integrity. Positioned within the Omega CRO ecosystem, the HelixLab Microbiology Laboratory provides traceable, auditable, and regulation-compliant central laboratory services specifically structured for clinical research requirements.

The Omega CRO Central Laboratory has a comprehensive microbiology analysis infrastructure capable of supporting customized tests tailored to the needs of each study. Our modern microbiology laboratories are equipped with advanced technology and are operated by experienced microbiology specialists, ensuring high standards of quality and reliability.

Our research team works in close collaboration with project owners/sponsors to design study-specific testing protocols. This optimizes analytical processes and increases efficiency in drug development and biotechnological research.

Microbiology Services Provided

  • Conventional culture methods: aerobic/anaerobic bacterial cultures; yeast and mold (fungal) cultures; semi-quantitative/quantitative evaluation when required.
  • Direct microscopy and staining: Gram staining, KOH preparation, and other specimen-specific rapid preliminary assessments.
  • Microorganism identification: phenotypic identification, biochemical panels and/or automation-based systems; confirmatory strategies when required.
  • Antimicrobial susceptibility testing (AST): disk diffusion, MIC-based methods, E-test/gradient strips and/or automation; CLSI/EUCAST-compliant reporting.
  • Molecular microbiology: pathogen detection by PCR/qPCR; multiplex approaches for selected targets; inhibitor control strategies.
  • Resistance markers: molecular confirmation of selected resistance genes/markers when protocol-required (e.g., MRSA/ESBL/carbapenemase-focused panels).
  • Sterility/contamination assessments: study-specific biosafety-driven contamination risk management and trend analysis; contamination and sterility testing at BSL-2 biosafety level.
  • Microbiome and translational research: sample processing and analytical preparation support for 16S rRNA and/or metagenomic approaches (depending on study design).

Pre-Analytical Processes

Study-specific pre-analytical requirements are defined for all specimen types prior to sample acceptance. Sampling instructions, transport conditions, time windows, and acceptance criteria are established through Standard Operating Procedures (SOPs).

Analytical Processes

All analytical testing is performed in accordance with validated methods and SOPs. Internal quality controls (QC), positive/negative controls, and methodological verifications are applied concurrently for each study.

Post-Analytical Processes and Reporting

Test results are reported in formats suitable for clinical research. Following quality review, data are transferred to sponsor or CRO systems in a timely and traceable manner.

Regulatory and Quality Compliance Framework

Regulatory and Quality Compliance Framework Microbiology laboratory operations are conducted in accordance with ICH GCP (International Council for Harmonisation-Good Clinical Practice), GCLP (Good Clinical Laboratory Practice), and ISO/IEC 17025 principles, with ALCOA+ data integrity, audit-ready documentation, and biosafety measures forming the core framework. SOP (Standard Operating Procedure) management, personnel competency tracking, and study-fit method validation including specificity, sensitivity, repeatability, and where applicable LoD (Limit of Detection) and LoQ (Limit of Quantification) are systematically implemented. Quality is ensured through internal and external controls such as QC (Quality Control) strains, control charts, and EQA (External Quality Assessment) participation. Deviation management is handled via a structured CAPA (Corrective and Preventive Action) approach, while data security, access control, audit trails, and archiving ensure full traceability and compliance.

Assistance in Clinical Research
  • Blood cultures / sterile body fluids: contamination risk management, appropriate volume and timing, rapid triage after a positive signal.
  • Urine specimens: quantitative culture and colony count with clinically relevant threshold-based reporting.
  • Respiratory specimens (swabs, sputum, BAL): specimen quality assessment (epithelial/leukocyte triage), selective culture strategies.
  • Wound/skin swabs: isolation strategies in polymicrobial specimens and differentiation of contamination.
  • Stool and GI specimens: pathogen screening using selective media; pre-analytical standardization for microbiome studies.
  • Isolation using selective/differential media; protocol-specific standardization of aerobic–anaerobic incubation conditions.
  • Semi-quantitative/quantitative cultures (e.g., urine, respiratory specimens) for burden assessment and comparability.
  • Contamination differentiation: separating specimen-related contamination from true pathogens; standardized reporting interpretation.
  • Gram staining for rapid triage and optimization of culture strategies (e.g., prioritization in polymicrobial specimens).
  • Rapid assessments such as KOH preparation for suspected fungal infections; appropriate culture condition selection.
  • Standardization of smear/preliminary reporting when defined in the study protocol.
  • Phenotypic and biochemical identification approaches; automation-assisted ID where applicable.
  • Confirmation strategy for difficult isolates: secondary-method confirmation and/or advanced verification workflows (study-fit).
  • ID standardization in multicenter studies: unified decision trees and reporting lexicons to ensure comparability.
  • CLSI/EUCAST-compliant method selection: disk diffusion, broth microdilution, gradient strips (E-test), and/or automation.
  • Study-specific MIC reporting with critical resistance phenotype confirmation workflows (e.g., suspected ESBL/carbapenemase).
  • Routine performance monitoring using QC strains; verification and trend analysis during lot changes.
  • Rapid pathogen confirmation using PCR/qPCR; multiplex panels where appropriate.
  • Analytical controls: extraction controls, inhibitor controls, positive/negative controls; spatial separation for contamination prevention.
  • Resistance markers: study-fit molecular confirmation of selected gene/marker targets when protocol-required.

Integration with the Omega Ecosystem

Microbiology services are delivered in an integrated manner with Core Lab, Omega Genetics, and Omega Biostorage infrastructures. This integration ensures data consistency and operational continuity throughout the entire specimen lifecycle.

Omega Bio Microbiology-Focused Diagnostic Kits

  • Rapid diagnostic kits for respiratory pathogens:
    Adenovirus, Influenza A/B, Respiratory Syncytial Virus (RSV), Group A Streptococcus, SARS-CoV-2, and combined SARS-CoV-2 & Influenza A/B rapid antigen test kits.
  • Diagnostic kits for gastrointestinal infections:
    Rotavirus, Adenovirus (fecal), Norovirus, Giardia, Entamoeba histolytica, Helicobacter pylori (antigen- and antibody-based), and combined Rotavirus & Adenovirus rapid test kits.
  • Bacterial and molecular microbiology kits (RT-PCR based):
    Group A Streptococcus qPCR, Salmonella qPCR, Salmonella enteritidis / typhimurium qPCR, and respiratory infection qPCR panels (multiplex pathogen detection kits).
  • Virological and serological microbiology kits:
    SARS-CoV-2 Spike and Nucleocapsid protein IgG ELISA kits, SARS-CoV-2 neutralizing antibody ELISA kits, and serological platforms for the assessment of viral infections.
  • Screening and supportive microbiology tests (protocol-dependent):
    Rapid antigen and antibody tests used for field screening, infection burden monitoring, and supportive microbiological assessments within clinical research protocols.

Home-Based Microbiology Sampling for Clinical Trials

In microbiology studies, sample quality and timing windows are the primary determinants of result reliability. Through the OmegaCare home-visit model, protocol-compliant home-based sample collection, sample preparation, and IATA (International Air Transport Association)-compliant shipment processes are managed via a traceable chain-of-custody workflow. During home visits, vital signs, required questionnaires, and AE documentation are recorded as part of standard source documentation.

Scope Exclusions & Advanced Virology Reference

The services described on this microbiology capability page include bacteriology, mycology, and clinical research–focused molecular microbiology analyses. However, virological analyses with high regulatory sensitivity are addressed as a separate, specialized capability due to their critical role in clinical research safety. Virological testing generates safety-critical outputs rather than merely supportive data.

partner infrastructures

Laboratory, analytical, and operational services provided within the Omega ecosystem are delivered through Omega’s internal units or authorized partner infrastructures that comply with applicable standards, depending on the nature of the study, regulatory requirements, and methodological scope. Accreditations, certifications, and official authorizations apply at the level of the unit or partner organization where the service is actually performed and are assessed on a study-specific basis for each service category.

For detailed technical information on advanced virology and viral safety services, please visit the dedicated capability page:

VIROLOGY